[Elucidation of dysfunctional mechanisms of retinal circulation in the rat models of glaucoma and exploration of novel therapeutic drugs].

Abstract

In recent times, glaucoma has become the leading cause of acquired blindness among the Japanese. As visual disorders markedly decrease the quality of life (QOL), it is important to develop new strategies for preventing the onset of and delaying the progression of glaucoma. Glaucoma has long since been recognized as a serious disease caused by increased intraocular pressure and subsequent injury and death of the neuronal retinal cells. Therefore, numerous studies have focused on the mechanisms that damage neuronal cells and on the drugs that possess protective effects in reversing this damage. However, injury to the retinal vasculature has been recently shown in animal models of glaucoma. Hence, thus far, only few papers have been published on retinal circulation in glaucoma. These study results have indicated that retinal circulation is altered in glaucoma and that this vascular abnormality may be the cause of and/or may accelerate retinal degeneration. In this report, we have attempted to elucidate the mechanisms of retinal circulation and explore novel drugs for the treatment of retinal circulation disorders. We have also introduced here our previous research results on retinal circulation. We reported that the drugs that improved retinal circulation, by intravitreal injection, in the rat model of glaucoma also inhibited retinal nerve injury, thereby representing possibilities that they might be novel candidate drugs for glaucoma prevention and treatment.

• Authors: Asami Mori, Tsutomu Nakahara, Yuki Kurauchi, Kenji Sakamoto, Kunio Ishii
• Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan (Yakugaku Zasshi) Vol. 133 Issue 12 Pg. 1343-50 ( 2013) ISSN: 1347-5231 [Electronic] Japan
• PMID: 24292182 (Publication Type: English Abstract, Journal Article, Review)

Chemical References

• Adrenergic beta-Antagonists
• Receptors, Adrenergic, beta
• Nitric Oxide

Topics

• Adrenergic beta-Antagonists (therapeutic use)
• Animals
• Disease Models, Animal
• Glaucoma (drug therapy, prevention & control)
• Humans
• Nitric Oxide (metabolism)
• Rats
• Receptors, Adrenergic, beta (metabolism)
• Retina (drug effects, physiopathology)